Clinical Trials Directory

Trials / Completed

CompletedNCT04100421

Exposure Of Bisphenol Analogues In Chronic Kidney Disease and Dialysis Patients

Study on the Level of Bisphenol Compounds in Patients With Chronic Kidney Disease and Renal Replacement Therapy and Relationship Between Bisphenols and Dialyzer Membrane

Status
Completed
Phase
Study type
Observational
Enrollment
154 (actual)
Sponsor
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

In this retrospective study, the serum levels of Bisphenol A (BPA) and three BPA analogs, namely, bisphenol B (BPB), bisphenol S (BPS), and bisphenol F (BPF), in patients with CKD, patients on dialysis therapy and healthy control were investigated to find out if BPA and BPA analogs accumulates in patients with chronic kidney disease (CKD), and if hemodialysis filters contribute to bisphenol burden in patients on hemodialysis (HD).

Conditions

Timeline

Start date
2017-06-01
Primary completion
2017-12-30
Completion
2018-06-30
First posted
2019-09-24
Last updated
2019-09-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04100421. Inclusion in this directory is not an endorsement.